Sep 01, 2019
- Sep 30, 2019
Thermo Fisher Scientific has worked with Sepsis Alliance, the Global Sepsis Alliance, and other advocates to raise awareness of the signs and symptoms of sepsis during Sepsis Awareness Month. Sepsis is the body’s overwhelming and life-threatening response to infection that can lead to tissue damage, organ failure, and death. In other words, it’s your body’s overactive and toxic response to an infection.
Supporters are encouraged to join together to raise awareness through social media, handing out brochures and stickers, giving talks, wearing Sepsis Awareness Ribbons, or holding awareness events.
We're pleased to offer the following educational events in support of Sepsis Awareness Month.
In this webinar, Gregory B. Seymann, MD, SFHM, Sean-Xavier Neath, MD, PHD, and Michael R Broyles, BS Pharm, PharmD will review the utility of PCT in the emergency department or inpatient hospital settings, and describes perspectives of three different clinicians and their approach to implementing this biomarker in clinical practice.
September 19, 12:00pm EDT
Mike Broyles, BS Pharm, PharmD, will describe the regulation and kinetics of procalcitonin during infection and review current biomarkers used in the management of bacterial infection. He will also explain the concept of PCT-aided antibiotic stewardship and how using a biomarker with greater specificity to bacterial infections improves clinical and health economic outcomes.
September 24, 2:00pm EDT
Appropriate antibiotic use is critical to improve patient outcomes and reduce adverse harm and antibiotic resistance. Half of all antibiotic use related to acute hospitalization for infection occurs after hospital discharge, yet most antibiotic stewardship programs don’t target prescribing at discharge. Thus, while antibiotics when prescribed appropriately can be life-saving, often times antibiotics prescribed at discharge extend beyond duration typically recommended for the infection and are inappropriate or unnecessary. Hosted by the Sepsis Alliance and sponsored by Thermo Fisher Scientific, this webinar will address the current state of antibiotic use at discharge, discuss why providers often overprescribe at discharge, and help improve prescribing and patient outcomes.
Did you know?
- More than 1.7 million people are diagnosed with sepsis in the US each year.1
- Nearly 270,000 sepsis patients will die each year in the US1 - that's more than prostate cancer, breast cancer, and AIDS combined!2
- Only 55% of US adults have heard of sepsis.3
- Sepsis is the number one inpatient hospital expense with costs over $27 billion.4,5
- Mortality from sepsis increases by as much as 8% for every hour that treatment is delayed.6
Visit our B·R·A·H·M·S PCT (Procalcitonin) Education page at thermofisher.com/aboutsepsis for videos, on-demand webinars and other educational materials about antibiotic stewardship.
Explore our Clinical Microbiology Webinar Library to watch webinars from experts working in the fields of Healthcare Associated Infections, sepsis, and antimicrobial stewardship, and discover advances in blood culture, susceptibility testing and other microbiology workflow solutions at Clinical Microbiology.